305 related articles for article (PubMed ID: 25676789)
1. Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.
Wen CC; Yee SW; Liang X; Hoffmann TJ; Kvale MN; Banda Y; Jorgenson E; Schaefer C; Risch N; Giacomini KM
Clin Pharmacol Ther; 2015 May; 97(5):518-25. PubMed ID: 25676789
[TBL] [Abstract][Full Text] [Related]
2. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
3. ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout.
Roberts RL; Wallace MC; Phipps-Green AJ; Topless R; Drake JM; Tan P; Dalbeth N; Merriman TR; Stamp LK
Pharmacogenomics J; 2017 Mar; 17(2):201-203. PubMed ID: 26810134
[TBL] [Abstract][Full Text] [Related]
4. ABCG2/BCRP dysfunction as a major cause of gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
[TBL] [Abstract][Full Text] [Related]
5. No association between MTHFR C677T and serum uric acid levels among Japanese with ABCG2 126QQ and SLC22A12 258WW.
Hinohara Y; Naito M; Okada R; Yin G; Higashibata T; Tamura T; Kawai S; Morita E; Wakai K; Matsuo H; Mori A; Hamajima N
Nagoya J Med Sci; 2013 Feb; 75(1-2):93-100. PubMed ID: 23544272
[TBL] [Abstract][Full Text] [Related]
6. Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.
Wallace MC; Roberts RL; Nanavati P; Miner JN; Dalbeth N; Topless R; Merriman TR; Stamp LK
Rheumatology (Oxford); 2018 Apr; 57(4):656-660. PubMed ID: 29342288
[TBL] [Abstract][Full Text] [Related]
7. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
Liu J; Yang W; Li Y; Wei Z; Dan X
BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in ATP-binding cassette transporter, sub-family G, member 2 (ABCG2/BCRP): genotype combinations and estimated functions.
Sakiyama M; Matsuo H; Takada Y; Nakamura T; Nakayama A; Takada T; Kitajiri S; Wakai K; Suzuki H; Shinomiya N
Drug Metab Pharmacokinet; 2014; 29(6):490-2. PubMed ID: 24869748
[TBL] [Abstract][Full Text] [Related]
9. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
10. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
[TBL] [Abstract][Full Text] [Related]
11. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species derived from xanthine oxidase interrupt dimerization of breast cancer resistance protein, resulting in suppression of uric acid excretion to the intestinal lumen.
Ogura J; Kuwayama K; Sasaki S; Kaneko C; Koizumi T; Yabe K; Tsujimoto T; Takeno R; Takaya A; Kobayashi M; Yamaguchi H; Iseki K
Biochem Pharmacol; 2015 Sep; 97(1):89-98. PubMed ID: 26119820
[TBL] [Abstract][Full Text] [Related]
13. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
[TBL] [Abstract][Full Text] [Related]
15. Identification of ABCG2 dysfunction as a major factor contributing to gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
[TBL] [Abstract][Full Text] [Related]
16. Association of ABCG2 rs2231142-A allele and serum uric acid levels in male and obese individuals in a Han Taiwanese population.
Cheng ST; Wu S; Su CW; Teng MS; Hsu LA; Ko YL
J Formos Med Assoc; 2017 Jan; 116(1):18-23. PubMed ID: 26792383
[TBL] [Abstract][Full Text] [Related]
17. Genetics of gout.
Choi HK; Zhu Y; Mount DB
Curr Opin Rheumatol; 2010 Mar; 22(2):144-51. PubMed ID: 20110790
[TBL] [Abstract][Full Text] [Related]
18. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
19. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
20. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.
Yamagishi K; Tanigawa T; Kitamura A; Köttgen A; Folsom AR; Iso H;
Rheumatology (Oxford); 2010 Aug; 49(8):1461-5. PubMed ID: 20421215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
